Article Details

Regulatory roundup: Roche's Cotellic among cancer drugs with declining approval outlook

Retrieved on: 2021-08-24 10:29:24

Tags for this article:

Click the tags to see associated articles and topics

Regulatory roundup: Roche's Cotellic among cancer drugs with declining approval outlook. View article details on hiswai:

Excerpt

The model uses data points from the individual drugs, clinical trials, regulatory milestones, company, and financial databases. Roche's Cotellic sees 15-point ...

Article found on: www.clinicaltrialsarena.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up